From Name

From Email

To Name

To Email

Message

Studies of DaxibotulinumtoxinA Injection to treat forehead lines and crow's feet produce positive results, Revance announces

from Plastic Surgery Practice

Studies of DaxibotulinumtoxinA Injection to treat forehead lines and crow's feet produce positive results, Revance announces Plastic Surgery Practice Revance Therapeutics Inc,, a biotechnology company focused on innovative aesthetic and therapeutic offerings, including its next-generation neuromodulator product, DaxibotulinumtoxinA for Injection, announces results for two Phase 2a open-label, dose escalation studies of its investigational drug candidate DaxibotulinumtoxinA for Injection in the treatment of dynamic forehead lines (FHL) following glabellar (frown) line injections and lateral canthal lines (LCL), commonly known as crow’s feet. READ MORE

more